Healthcare entity
regulation is the sole category represented across all 2 tracked stories. Duane Boise is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Across a 21-day span, the pace is roughly 0.7 stories per week. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window.
Last mentioned: Aug 16, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 2 tracked stories. Duane Boise is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Across a 21-day span, the pace is roughly 0.7 stories per week. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window. At 6, the average consequence score sits above the same-window beat average of 5.6. MMJ International Holdings, Inc. appears in 2 tracked Healthcare stories published from July 27, 2026 through August 16, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 240 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MMJ International Holdings, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Scheduled DEA hearing on rescheduling
A DEA administrative hearing is set to take place, which CEO Duane Boise calls less significant than the appellate court action.
MMJ announces advancement of legal challenge
Company issues press release declaring that the D.C. Circuit challenge has advanced and that the operative legal event is the court review, not the upcoming DEA hearing.
Statement of Issues filed
MMJIH files a Statement of Issues in the D.C. Circuit Court of Appeals seeking vacatur of the Final Order.
Acting Attorney General issues Final Order
Todd Blanche places marijuana into Schedule III of the Controlled Substances Act via a Final Order.
Initial DEA hearing process begins
A hearing process on marijuana rescheduling begins under the Controlled Substances Act, later terminated by the government according to petitioners.
Health systems and health IT vendors building around CMS's hemp-derived cannabinoid initiative are on contested regulatory ground. A successful federal challenge could stay or remand the program, changing compliance and reimbursement calculations.
MMJ International Holdings' appeal to the D.C. Circuit exposes a procedural flaw in the DEA's marijuana rescheduling that could delay patient access to new cannabinoid medicines and create confusion for healthcare providers trying to navigate the shifting regulatory landscape.
Source: tennesseedaily.com · pr-inside.com
MMJ International Holdings, Inc. is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
